Device Medical Device

(Bq9) Coronary Ivus

Payments companies reported to CMS as associated with (Bq9) Coronary Ivus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$95Kassociated payments (2023-2025)

341clinicians with associated payments

2companies reporting

By year

2023 $1,093

2024 $94K

Payments reported as associated with (Bq9) Coronary Ivus, per program year, as reported to CMS.

Who makes it

Philips North America LLC $94K associated with (Bq9) Coronary Ivus (2023-2025)
Philips Electronics North America Corporation $173 associated with (Bq9) Coronary Ivus (2023-2025)

Specialties most often involved

Cardiovascular Disease $46K

Interventional Cardiology $35K

Internal Medicine $4,093

Medical $3,080

Family Medicine $543

Thoracic Surgery (Cardiothoracic Vascular Surgery) $422

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (Bq9) Coronary Ivus

These are the largest totals companies reported as associated with (Bq9) Coronary Ivus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Allen Jeremias	E Setauket, NY	Cardiovascular Disease	$12,377.79
Omar Qaqish	Little Rock, AR	Cardiovascular Disease	$10,732.87
Jasvindar Singh	Saint Louis, MO	Interventional Cardiology	$4,694.14
James Torey	Saint Clair Shores, MI	Medical	$2,836.21
Paulrajan Manoharan	Mcallen, TX	Cardiovascular Disease	$2,310.05
Carlos Espinoza	Rocky Mount, NC	Cardiovascular Disease	$2,092.63
Ankita Aggarwal	Jersey City, NJ	Cardiovascular Disease	$2,089.29
Pranoti Hiremath	Baltimore, MD	Internal Medicine	$1,940.96
Karim Al-Azizi	Plano, TX	Interventional Cardiology	$1,872.35
Prasanna Manjini Sengodan	Moberly, MO	Interventional Cardiology	$1,815.63

Prescribed (Bq9) Coronary Ivus?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.